ALB and metabolic disease: A study on an animal model tested whether nanoparticles of berberine and bovine albumin may treat liver fibrosis—the mouse model showed efficacy, but these findings cannot be directly applied to human therapy (particularly since this study addressed liver damage caused by chemical means like CCl4 rather than metabolic diseases) [71].